(Q51564465)
Statements
A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group (English)
1 reference
Landgraf R
1 reference
1 March 1999
1 reference
22
1 reference
3
1 reference
463-467
1 reference